Mohamed Kharfan-Dabaja, MD, MBA

Congratulations to Dr Kassim @DrAdetolaKassim global leader in the field of #SCD Thank y’all investigators, pts, family for this ground breaking research! Data just published in NEJM Evi @NEJM @jordanberlin5 @VUMC_Cancer @VUMCHemOnc @VUMCDiscoveries @ASTCT @CIBMTR @nmdp_org

SQ blinatumomab is highly effective in R-R ALL with CR/CRh rate of 77%, MRD-negativity rate of 91%, and 12-month OS rate of 63-70%. The 250 µg/500 µg dose was selected as the recommended phase 2 dose. @MDAndersonNews #Leukemia doi.org/10.1016/s2352-… #leusm

🚨 Thrilled to share our @JCO_ASCO publication from the ACCESS study! Honored to co-chair this pivotal work at @cityofhope with @CIBMTR & @nmdp_org—advancing access to life-saving #BMT 🔗 ascopubs.org/doi/10.1200/JC… 🔗 go.nmdp.org/3SRTmgf

We are happy to share our recently published clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and CAR T-cell therapy in chronic lymphocytic leukemia on behalf of #ASTCT @MediHumdani @mshadman @DrAmbuj … pubmed.ncbi.nlm.nih.gov/40514010/

It is a true honor to host @Dr_AmerZeidan who is presenting an inspiring lecture at our Mayo Clinic Comprehensive Cancer Center grand rounds on advances and remaining challenges in myelodysplastic syndrome. @MayoClinic @RManochakian

📣It is a true pleasure to host Professor @Dr_AmerZeidan A great leader in #HematologicMalignancies & a wonderful colleague from @Yale, giving an outstanding talk at the @MayoClinic FL @MayoCancerCare #GrandRounds on a very important topic: #MyeloDysplasticSyndrome #MDS

US Geriatric Assessment Practices for Older Adults Undergoing Hematopo... sciencedirect.com/science/articl… In a first of its kind team effort with a so grateful for the commitment and mentorship by all! @MediHumdani,Andy Artz, Paul Carpenter @ASTCT improving our survey methodologies🤞🏼

1/2🔥🚨@OncoAlert Hot off the press. Just published @SpringerNature #CurrentOncologyReports by our team @MayoCancerCare A #Review Article on: ✅The #Antibody-#Drug #Conjugates (#ADCs) Therapeutic 💊#Revolution in #LungCancer 🫁(#NSCLC & #SCLC). 👇🏻 link.springer.com/article/10.100…

📣Join us at the 34th ANNUAL @MayoCancerCare Florida #Hematology/#Oncology Reviews at Amelia Island #RitzCarlton (July 2025). Comprehensive #CME #Practical (in-person & virtual) Conference, with AMAZING speakers from @MayoClinic & other GREAT centers. 👇🏼 tinyurl.com/56tmx6j7

México was present in EBMT meeting in Florence. Data of 1700 transplants in autoimmune diseases and reduced doses of post-transplant cyclophosphamide were presented @TheEBMT @ASTCT @ASTCT_Journal @ContactoAmeh @ASH_hematology @MayoClinic

Keep shining AUB. QS Ranking 2025: MEDICINE Number 1 in the MENA region Number 132 in the World

Congratulations to my colleague and dear friend @aljurf100 for being the recipient of the 2025 Steven E. Weinberger Award for Physician Executives/Leaders by the American College of Physicians @ACPIMPhysicians

The largest experience of autologous hematopoietic cell transplantation in 1700 patients with autoimmune diseases, in the outpatient setting, using the “Mexican method”. “Yes, it can be done” “Si se puede”@BMTjournal @GuillermoRuizA5 @dgomezalmaguer @GomezDLeonMD

Happy to share our recent manuscript on outcomes of anti-CD19 #CART for #lymphoma in octogenarians (80 years of age or older). 👉🏻CR rate 71.4% 👉🏻1-year OS 61.2% 👉🏻1-year PFS 47.6% 👉🏻1-year NRM 11.6% 🙏🏻 to all collaborators Link 🔗 rdcu.be/ebQ47

For the seventh consecutive year, Mayo Clinic is ranked No. 1 on @Newsweek’s World’s Best Hospitals 2025 list. mayocl.in/4hU17Ny

Congrats to @GiraltSergio, who will give the honorary Mortimer M. Bortin Lecture today at #Tandem25. He will give an overview of the rapid advances that have changed transplant practice and what he sees for the future. @MSKCancerCenter buff.ly/3EzMm3M 5:15 p.m. HST

Congratulations to ASTCT Public Service Award recipients Mary E. Flowers, MD, of @fredhutch and Marcos de Lima, MD, of @OhioState. #Tandem25

Congrats, Dr. Giralt as the 2025 @CIBMTR Mortimer M. Bortin Lecture! @ASTCT @CIBMTR Tandem Meetings #Tandem25

Attending #Tandem25 @ASTCT @CIBMTR Tandem Meetings? Check out Thursday's Spotlight Session at 330 pm Hawaii time on the @ASTCT @nmdp_org ACCESS Initiative focused on ensuring transplant and cell therapy for all patients. Come join us! vmx.m-anage.com/us/tandem2025/…